俄罗斯暂停后恢复新冠肺炎疫苗试验:医务人员

2020-11-19 18:03

Russia resumes COVID-19 vaccine trial after pause: medical staff CKG世界播

俄罗斯暂停后恢复新冠肺炎疫苗试验:医务人员CKG世界播


MOSCOW (Reuters) - Russia has resumed the vaccination of new volunteers in its trial for its flagship COVID-19 Sputnik V vaccine after a short pause, staff at six of 29 trial clinics said, as Moscow moves to accelerate plans to inoculate the population. CKG世界播

莫斯科(路透社)-俄罗斯29家试验诊所中的6家的工作人员表示,俄罗斯在短暂暂停后,已经恢复了旗舰新冠肺炎人造卫星V疫苗试验中新志愿者的疫苗接种,莫斯科正在采取行动,加快人口接种计划。CKG世界播


At the end of October, eight clinics told Reuters that the trial had been temporarily paused for new volunteers, with some clinics citing high demand and a shortage of doses. CKG世界播

10月底,八家诊所告诉路透社,针对新的志愿者,这项试验已经暂停,一些诊所称需求很高,而且缺乏剂量。CKG世界播


Alexander Gintsburg, director of the Gamaleya Institute, which developed and manufactures the vaccine, said at the time that the uptake of new volunteers had only slowed because of a decision to focus on giving those already vaccinated a second dose. CKG世界播

开发和生产这种疫苗的伽玛利亚研究所(Gamaleya Institute)所长亚历山大·金茨堡(Alexander Gintsburg)当时表示,吸收新志愿者只是因为决定专注于给那些已经接种了疫苗的人接种第二针疫苗。CKG世界播


"Vaccination has resumed. Starting on Monday, we are doing the first component (of the two-dose jab) again," a staff member at Moscow Clinic Number 46 told Reuters this week. CKG世界播

莫斯科第46号诊所的一名工作人员本周告诉路透社:“疫苗接种已经恢复。从周一开始,我们将再次进行(双剂注射的)第一步注射,”莫斯科第46号诊所的一名工作人员本周告诉路透社。CKG世界播


Reuters reporters saw queues of people waiting for a pre-vaccination medical examination at three Moscow trial clinics on Monday, Wednesday and Thursday. CKG世界播

路透社记者周一、周三和周四在莫斯科的三家试验诊所看到排队等待疫苗接种前体检的人。CKG世界播


"We have resumed vaccination. Quite a lot of people come to get inoculated," one health worker at Clinic number 170 said. CKG世界播

170号诊所的一名卫生工作者说:“我们已经恢复了疫苗接种。来接种疫苗的人相当多。”CKG世界播


As of Nov. 11, more than 20,000 volunteers had received the first of the two shots, and over 16,000 volunteers the first and second doses, according to the Russian Direct Investment Fund (RDIF). Vaccine developers intend to give the vaccine to 40,000 people initially. CKG世界播

根据俄罗斯直接投资基金(RDIF)的数据,截至11月11日,超过2万名志愿者接受了两针中的第一针,超过1.6万名志愿者接受了第一针和第二针。疫苗研发人员打算最初将疫苗接种给4万人。CKG世界播


RDIF, which is backing and marketing the vaccine, did not respond to requests for comment about the pace of the trial. CKG世界播

支持和营销该疫苗的RDIF没有回应有关试验速度的置评请求。CKG世界播


Alexei Kuznetsov, an aide to the health minister, said: "The clinical trial is going according to plan. At the same time, a trial involving volunteers aged over 60 is continuing." CKG世界播

卫生部长的助手阿列克谢·库兹涅佐夫(Alexei Kuznetsov)说:“临床试验正在按计划进行。与此同时,一项涉及60岁以上志愿者的试验仍在继续。”CKG世界播


Russian officials and vaccine developers have previously flagged challenges in ramping up output of Sputnik V, and initial estimates of 30 million doses to be produced by year-end were revised down last month by the industry minister to just over 2 million doses. CKG世界播

俄罗斯官员和疫苗研发人员此前曾指出,提高Sputnik V的产量面临挑战,工业部长上个月将最初估计的年底前生产3000万剂的疫苗下调至略高于200万剂。CKG世界播


President Vladimir Putin said in October that Russia was facing challenges scaling up production due to problems with equipment availability, but hoped to start mass vaccinations by the end of the year. CKG世界播

俄罗斯总统弗拉基米尔·普京(Vladimir Putin)在10月份表示,由于设备供应方面的问题,俄罗斯在扩大产量方面面临挑战,但希望在今年年底前开始大规模接种疫苗。CKG世界播

© 2016 世界播 www.shijiebobao.com 中国互联网举报中心 京ICP证140141号 鄂ICP备18018000号-1
违法和不良信息举报: